HEADER TRANSFERASE(AMINOTRANSFERASE) 06-SEP-94 2CST TITLE CRYSTAL STRUCTURE OF THE CLOSED FORM OF CHICKEN CYTOSOLIC ASPARTATE TITLE 2 AMINOTRANSFERASE AT 1.9 ANGSTROMS RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.6.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 ORGAN: HEART; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 32644 KEYWDS TRANSFERASE(AMINOTRANSFERASE) EXPDTA X-RAY DIFFRACTION AUTHOR V.N.MALASHKEVICH,B.V.STROKOPYTOV,V.V.BORISOV REVDAT 4 29-NOV-17 2CST 1 HELIX REVDAT 3 13-JUL-11 2CST 1 VERSN REVDAT 2 24-FEB-09 2CST 1 VERSN REVDAT 1 30-NOV-94 2CST 0 JRNL AUTH V.N.MALASHKEVICH,B.V.STROKOPYTOV,V.V.BORISOV,Z.DAUTER, JRNL AUTH 2 K.S.WILSON,Y.M.TORCHINSKY JRNL TITL CRYSTAL STRUCTURE OF THE CLOSED FORM OF CHICKEN CYTOSOLIC JRNL TITL 2 ASPARTATE AMINOTRANSFERASE AT 1.9 A RESOLUTION. JRNL REF J.MOL.BIOL. V. 247 111 1995 JRNL REFN ISSN 0022-2836 JRNL PMID 7897655 JRNL DOI 10.1006/JMBI.1994.0126 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.G.HARUTYUNYAN,V.N.MALASHKEVICH,V.M.KOCHKINA,Y.M.TORCHINSKY REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX OF CHICKEN REMARK 1 TITL 2 CYTOSOLIC ASPARTATE AMINOTRANSFERASE WITH 2-OXOGLUTARATE REMARK 1 EDIT P.CHRISTEN, D.E.METZLER REMARK 1 REF TRANSAMINASES 164 1985 REMARK 1 PUBL JOHN WILEY AND SONS, NEW YORK REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 67544 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 768 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.900 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CST COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.20000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.15000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.15000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.20000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 63.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE TRANSFORMATION PRESENTED ON *MTRIX* RECORDS BELOW WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR CHAIN B WHEN APPLIED TO REMARK 300 CHAIN A. REMARK 300 REMARK 300 THE TRANSFORMATION PRESENTED ON *MTRIX* RECORDS BELOW WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR CHAIN *B* WHEN APPLIED TO REMARK 300 CHAIN *A*. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 44 CD GLU A 44 OE1 0.075 REMARK 500 GLU A 141 CD GLU A 141 OE1 0.070 REMARK 500 GLU A 265 CD GLU A 265 OE1 -0.070 REMARK 500 GLU A 288 CD GLU A 288 OE1 0.068 REMARK 500 GLU A 342 CD GLU A 342 OE2 0.068 REMARK 500 GLU A 371 CD GLU A 371 OE2 0.068 REMARK 500 GLU A 376 CD GLU A 376 OE1 0.070 REMARK 500 GLU B 26 CD GLU B 26 OE1 0.072 REMARK 500 GLU B 44 CD GLU B 44 OE2 0.067 REMARK 500 GLU B 78 CD GLU B 78 OE2 0.074 REMARK 500 GLU B 141 CD GLU B 141 OE1 0.085 REMARK 500 GLU B 288 CD GLU B 288 OE1 0.066 REMARK 500 GLU B 376 CD GLU B 376 OE2 0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 29 CB - CG - OD1 ANGL. DEV. = -7.0 DEGREES REMARK 500 ASP A 29 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ARG A 41 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ASP A 91 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ARG A 99 N - CA - CB ANGL. DEV. = -11.4 DEGREES REMARK 500 ARG A 99 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 120 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 120 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 ASP A 176 CB - CG - OD1 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 176 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 203 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP A 278 CB - CG - OD1 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP B 23 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP B 27 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP B 29 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ARG B 41 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ASP B 63 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ARG B 80 NE - CZ - NH1 ANGL. DEV. = 6.1 DEGREES REMARK 500 ARG B 80 NE - CZ - NH2 ANGL. DEV. = -5.2 DEGREES REMARK 500 ASP B 90 CB - CG - OD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG B 99 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ARG B 99 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG B 120 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 ASP B 149 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP B 149 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP B 169 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 169 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP B 234 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 234 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP B 236 CB - CG - OD2 ANGL. DEV. = -6.5 DEGREES REMARK 500 ASP B 321 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP B 328 CB - CG - OD1 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP B 328 CB - CG - OD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP B 355 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 355 CB - CG - OD2 ANGL. DEV. = -6.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 160 -69.99 -150.18 REMARK 500 LEU A 262 35.02 -99.87 REMARK 500 THR A 294 -61.17 -109.38 REMARK 500 SER A 296 -60.24 74.15 REMARK 500 ALA B 3 97.75 65.30 REMARK 500 TYR B 160 -65.85 -145.05 REMARK 500 SER B 230 -11.16 -145.82 REMARK 500 THR B 294 -60.57 -103.26 REMARK 500 SER B 296 -60.89 74.33 REMARK 500 GLU B 342 -81.56 -57.27 REMARK 500 SER B 343 -34.46 -38.79 REMARK 500 THR B 363 -86.14 -65.00 REMARK 500 HIS B 378 42.25 87.35 REMARK 500 LEU B 397 -85.04 -41.82 REMARK 500 THR B 409 -69.57 -106.38 REMARK 500 LYS B 410 -89.23 -57.45 REMARK 500 ILE B 411 -1.82 -56.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THE ACTIVE SITE COMPRISES THE RESIDUES REMARK 800 INTERACTING WITH COENZYME AND INHIBITOR. NOTE THAT RESIDUES TYR REMARK 800 70, ARG 292, SER 296, AND ASN 297 OF ONE SUBUNIT CONTRIBUTE TO REMARK 800 THE ACTIVE SITE OF THE OTHER SUBUNIT IN THE DIMER. REMARK 800 REMARK 800 SITE_IDENTIFIER: BCT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THE ACTIVE SITE COMPRISES THE RESIDUES REMARK 800 INTERACTING WITH COENZYME AND INHIBITOR. NOTE THAT RESIDUES TYR REMARK 800 70, ARG 292, SER 296, AND ASN 297 OF ONE SUBUNIT CONTRIBUTE TO REMARK 800 THE ACTIVE SITE OF THE OTHER SUBUNIT IN THE DIMER. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAE A 414 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP B 413 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAE B 414 DBREF 2CST A 2 412 UNP P00504 AATC_CHICK 1 411 DBREF 2CST B 2 412 UNP P00504 AATC_CHICK 1 411 SEQRES 1 A 411 ALA ALA SER ILE PHE ALA ALA VAL PRO ARG ALA PRO PRO SEQRES 2 A 411 VAL ALA VAL PHE LYS LEU THR ALA ASP PHE ARG GLU ASP SEQRES 3 A 411 GLY ASP SER ARG LYS VAL ASN LEU GLY VAL GLY ALA TYR SEQRES 4 A 411 ARG THR ASP GLU GLY GLN PRO TRP VAL LEU PRO VAL VAL SEQRES 5 A 411 ARG LYS VAL GLU GLN LEU ILE ALA GLY ASP GLY SER LEU SEQRES 6 A 411 ASN HIS GLU TYR LEU PRO ILE LEU GLY LEU PRO GLU PHE SEQRES 7 A 411 ARG ALA ASN ALA SER ARG ILE ALA LEU GLY ASP ASP SER SEQRES 8 A 411 PRO ALA ILE ALA GLN LYS ARG VAL GLY SER VAL GLN GLY SEQRES 9 A 411 LEU GLY GLY THR GLY ALA LEU ARG ILE GLY ALA GLU PHE SEQRES 10 A 411 LEU ARG ARG TRP TYR ASN GLY ASN ASN ASN THR ALA THR SEQRES 11 A 411 PRO VAL TYR VAL SER SER PRO THR TRP GLU ASN HIS ASN SEQRES 12 A 411 SER VAL PHE MET ASP ALA GLY PHE LYS ASP ILE ARG THR SEQRES 13 A 411 TYR ARG TYR TRP ASP ALA ALA LYS ARG GLY LEU ASP LEU SEQRES 14 A 411 GLN GLY LEU LEU ASP ASP MET GLU LYS ALA PRO GLU PHE SEQRES 15 A 411 SER ILE PHE ILE LEU HIS ALA CYS ALA HIS ASN PRO THR SEQRES 16 A 411 GLY THR ASP PRO THR PRO ASP GLU TRP LYS GLN ILE ALA SEQRES 17 A 411 ALA VAL MET LYS ARG ARG CYS LEU PHE PRO PHE PHE ASP SEQRES 18 A 411 SER ALA TYR GLN GLY PHE ALA SER GLY SER LEU ASP LYS SEQRES 19 A 411 ASP ALA TRP ALA VAL ARG TYR PHE VAL SER GLU GLY PHE SEQRES 20 A 411 GLU LEU PHE CYS ALA GLN SER PHE SER LYS ASN PHE GLY SEQRES 21 A 411 LEU TYR ASN GLU ARG VAL GLY ASN LEU SER VAL VAL GLY SEQRES 22 A 411 LYS ASP GLU ASP ASN VAL GLN ARG VAL LEU SER GLN MET SEQRES 23 A 411 GLU LYS ILE VAL ARG THR THR TRP SER ASN PRO PRO SER SEQRES 24 A 411 GLN GLY ALA ARG ILE VAL ALA THR THR LEU THR SER PRO SEQRES 25 A 411 GLN LEU PHE ALA GLU TRP LYS ASP ASN VAL LYS THR MET SEQRES 26 A 411 ALA ASP ARG VAL LEU LEU MET ARG SER GLU LEU ARG SER SEQRES 27 A 411 ARG LEU GLU SER LEU GLY THR PRO GLY THR TRP ASN HIS SEQRES 28 A 411 ILE THR ASP GLN ILE GLY MET PHE SER PHE THR GLY LEU SEQRES 29 A 411 ASN PRO LYS GLN VAL GLU TYR MET ILE LYS GLU LYS HIS SEQRES 30 A 411 ILE TYR LEU MET ALA SER GLY ARG ILE ASN MET CYS GLY SEQRES 31 A 411 LEU THR THR LYS ASN LEU ASP TYR VAL ALA LYS SER ILE SEQRES 32 A 411 HIS GLU ALA VAL THR LYS ILE GLN SEQRES 1 B 411 ALA ALA SER ILE PHE ALA ALA VAL PRO ARG ALA PRO PRO SEQRES 2 B 411 VAL ALA VAL PHE LYS LEU THR ALA ASP PHE ARG GLU ASP SEQRES 3 B 411 GLY ASP SER ARG LYS VAL ASN LEU GLY VAL GLY ALA TYR SEQRES 4 B 411 ARG THR ASP GLU GLY GLN PRO TRP VAL LEU PRO VAL VAL SEQRES 5 B 411 ARG LYS VAL GLU GLN LEU ILE ALA GLY ASP GLY SER LEU SEQRES 6 B 411 ASN HIS GLU TYR LEU PRO ILE LEU GLY LEU PRO GLU PHE SEQRES 7 B 411 ARG ALA ASN ALA SER ARG ILE ALA LEU GLY ASP ASP SER SEQRES 8 B 411 PRO ALA ILE ALA GLN LYS ARG VAL GLY SER VAL GLN GLY SEQRES 9 B 411 LEU GLY GLY THR GLY ALA LEU ARG ILE GLY ALA GLU PHE SEQRES 10 B 411 LEU ARG ARG TRP TYR ASN GLY ASN ASN ASN THR ALA THR SEQRES 11 B 411 PRO VAL TYR VAL SER SER PRO THR TRP GLU ASN HIS ASN SEQRES 12 B 411 SER VAL PHE MET ASP ALA GLY PHE LYS ASP ILE ARG THR SEQRES 13 B 411 TYR ARG TYR TRP ASP ALA ALA LYS ARG GLY LEU ASP LEU SEQRES 14 B 411 GLN GLY LEU LEU ASP ASP MET GLU LYS ALA PRO GLU PHE SEQRES 15 B 411 SER ILE PHE ILE LEU HIS ALA CYS ALA HIS ASN PRO THR SEQRES 16 B 411 GLY THR ASP PRO THR PRO ASP GLU TRP LYS GLN ILE ALA SEQRES 17 B 411 ALA VAL MET LYS ARG ARG CYS LEU PHE PRO PHE PHE ASP SEQRES 18 B 411 SER ALA TYR GLN GLY PHE ALA SER GLY SER LEU ASP LYS SEQRES 19 B 411 ASP ALA TRP ALA VAL ARG TYR PHE VAL SER GLU GLY PHE SEQRES 20 B 411 GLU LEU PHE CYS ALA GLN SER PHE SER LYS ASN PHE GLY SEQRES 21 B 411 LEU TYR ASN GLU ARG VAL GLY ASN LEU SER VAL VAL GLY SEQRES 22 B 411 LYS ASP GLU ASP ASN VAL GLN ARG VAL LEU SER GLN MET SEQRES 23 B 411 GLU LYS ILE VAL ARG THR THR TRP SER ASN PRO PRO SER SEQRES 24 B 411 GLN GLY ALA ARG ILE VAL ALA THR THR LEU THR SER PRO SEQRES 25 B 411 GLN LEU PHE ALA GLU TRP LYS ASP ASN VAL LYS THR MET SEQRES 26 B 411 ALA ASP ARG VAL LEU LEU MET ARG SER GLU LEU ARG SER SEQRES 27 B 411 ARG LEU GLU SER LEU GLY THR PRO GLY THR TRP ASN HIS SEQRES 28 B 411 ILE THR ASP GLN ILE GLY MET PHE SER PHE THR GLY LEU SEQRES 29 B 411 ASN PRO LYS GLN VAL GLU TYR MET ILE LYS GLU LYS HIS SEQRES 30 B 411 ILE TYR LEU MET ALA SER GLY ARG ILE ASN MET CYS GLY SEQRES 31 B 411 LEU THR THR LYS ASN LEU ASP TYR VAL ALA LYS SER ILE SEQRES 32 B 411 HIS GLU ALA VAL THR LYS ILE GLN HET PLP A 413 15 HET MAE A 414 8 HET PLP B 413 15 HET MAE B 414 8 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM MAE MALEIC ACID HETSYN PLP VITAMIN B6 PHOSPHATE FORMUL 3 PLP 2(C8 H10 N O6 P) FORMUL 4 MAE 2(C4 H4 O4) FORMUL 7 HOH *768(H2 O) HELIX 1 1A ALA A 16 GLU A 26 1 11 HELIX 2 2A PRO A 51 GLY A 62 1 12 HELIX 3 3A PRO A 77 LEU A 88 1 12 HELIX 4 4A PRO A 93 GLN A 97 1 5 HELIX 5 5A GLY A 107 TRP A 122 1 16 HELIX 6 6A GLU A 141 ALA A 150 1 10 HELIX 7 7A LEU A 170 LYS A 179 1 10 HELIX 8 8A PRO A 202 ARG A 215 1 14 HELIX 9 9A LEU A 233 GLU A 246 1 14 HELIX 10 10A GLU A 277 THR A 294 1 18 HELIX 11 11A SER A 300 THR A 311 1 12 HELIX 12 12A PRO A 313 LEU A 344 1 32 HELIX 13 13A ASN A 351 ASP A 355 1 5 HELIX 14 14A PRO A 367 LYS A 377 1 11 HELIX 15 15A ASN A 396 ILE A 411 1 16 HELIX 16 1B ALA B 16 GLU B 26 1 11 HELIX 17 2B PRO B 51 GLY B 62 1 12 HELIX 18 3B PRO B 77 LEU B 88 1 12 HELIX 19 4B PRO B 93 GLN B 97 1 5 HELIX 20 5B GLY B 107 TRP B 122 1 16 HELIX 21 6B GLU B 141 ALA B 150 1 10 HELIX 22 7B LEU B 170 LYS B 179 1 10 HELIX 23 8B PRO B 202 ARG B 215 1 14 HELIX 24 9B LEU B 233 GLU B 246 1 14 HELIX 25 10B GLU B 277 THR B 294 1 18 HELIX 26 11B SER B 300 THR B 311 1 12 HELIX 27 12B PRO B 313 LEU B 344 1 32 HELIX 28 13B ASN B 351 ASP B 355 1 5 HELIX 29 14B PRO B 367 LYS B 377 1 11 HELIX 30 15B ASN B 396 ILE B 411 1 16 SHEET 1 ASA 2 VAL A 33 ASN A 34 0 SHEET 2 ASA 2 ILE A 379 TYR A 380 1 N TYR A 380 O VAL A 33 SHEET 1 ASB 7 VAL A 100 LEU A 106 0 SHEET 2 ASB 7 VAL A 267 VAL A 273 -1 O VAL A 272 N GLY A 101 SHEET 3 ASB 7 LEU A 250 SER A 255 -1 N LEU A 250 O VAL A 273 SHEET 4 ASB 7 PHE A 218 SER A 223 1 O PRO A 219 N PHE A 251 SHEET 5 ASB 7 ILE A 185 HIS A 189 1 N PHE A 186 O PHE A 218 SHEET 6 ASB 7 VAL A 133 SER A 136 1 N TYR A 134 O ILE A 185 SHEET 7 ASB 7 ASP A 154 TYR A 158 1 O ASP A 154 N VAL A 133 SHEET 1 ASC 2 TRP A 161 ASP A 162 0 SHEET 2 ASC 2 GLY A 167 LEU A 168 -1 O GLY A 167 N ASP A 162 SHEET 1 ASD 2 PHE A 360 PHE A 362 0 SHEET 2 ASD 2 ARG A 386 ASN A 388 -1 O ILE A 387 N SER A 361 SHEET 1 BSA 2 VAL B 33 ASN B 34 0 SHEET 2 BSA 2 ILE B 379 TYR B 380 1 N TYR B 380 O VAL B 33 SHEET 1 BSB 7 VAL B 100 LEU B 106 0 SHEET 2 BSB 7 VAL B 267 VAL B 273 -1 O VAL B 272 N GLY B 101 SHEET 3 BSB 7 LEU B 250 SER B 255 -1 N LEU B 250 O VAL B 273 SHEET 4 BSB 7 PHE B 218 SER B 223 1 O PRO B 219 N PHE B 251 SHEET 5 BSB 7 ILE B 185 HIS B 189 1 N PHE B 186 O PHE B 218 SHEET 6 BSB 7 VAL B 133 SER B 136 1 N TYR B 134 O ILE B 185 SHEET 7 BSB 7 ASP B 154 TYR B 158 1 O ASP B 154 N VAL B 133 SHEET 1 BSC 2 TRP B 161 ASP B 162 0 SHEET 2 BSC 2 GLY B 167 LEU B 168 -1 O GLY B 167 N ASP B 162 SHEET 1 BSD 2 PHE B 360 PHE B 362 0 SHEET 2 BSD 2 ARG B 386 ASN B 388 -1 O ILE B 387 N SER B 361 LINK NZ LYS A 258 C4A PLP A 413 1555 1555 1.29 LINK NZ LYS B 258 C4A PLP B 413 1555 1555 1.29 CISPEP 1 SER A 137 PRO A 138 0 -1.16 CISPEP 2 ASN A 194 PRO A 195 0 12.80 CISPEP 3 SER B 137 PRO B 138 0 0.70 CISPEP 4 ASN B 194 PRO B 195 0 12.20 SITE 1 ACT 24 VAL A 15 VAL A 17 PHE A 18 VAL A 37 SITE 2 ACT 24 GLY A 38 ALA A 39 TYR B 70 GLY A 107 SITE 3 ACT 24 GLY A 108 THR A 109 TRP A 140 ASN A 194 SITE 4 ACT 24 ASP A 222 ALA A 224 TYR A 225 SER A 255 SITE 5 ACT 24 LYS A 258 ARG A 266 ARG B 292 SER B 296 SITE 6 ACT 24 ASN B 297 PHE A 360 ARG A 386 MAE A 414 SITE 1 BCT 24 VAL B 15 VAL B 17 PHE B 18 VAL B 37 SITE 2 BCT 24 GLY B 38 ALA B 39 TYR A 70 GLY B 107 SITE 3 BCT 24 GLY B 108 THR B 109 TRP B 140 ASN B 194 SITE 4 BCT 24 ASP B 222 ALA B 224 TYR B 225 SER B 255 SITE 5 BCT 24 LYS B 258 ARG B 266 ARG A 292 SER A 296 SITE 6 BCT 24 ASN A 297 PHE B 360 ARG B 386 MAE B 414 SITE 1 AC1 15 GLY A 107 GLY A 108 THR A 109 TRP A 140 SITE 2 AC1 15 ASN A 194 ASP A 222 ALA A 224 TYR A 225 SITE 3 AC1 15 SER A 255 SER A 257 LYS A 258 ARG A 266 SITE 4 AC1 15 MAE A 414 HOH A 416 TYR B 70 SITE 1 AC2 10 PHE A 18 VAL A 37 GLY A 38 TRP A 140 SITE 2 AC2 10 ASN A 194 ARG A 386 PLP A 413 HOH A 416 SITE 3 AC2 10 HOH A 423 ARG B 292 SITE 1 AC3 15 TYR A 70 GLY B 107 GLY B 108 THR B 109 SITE 2 AC3 15 TRP B 140 ASN B 194 ASP B 222 ALA B 224 SITE 3 AC3 15 TYR B 225 SER B 255 SER B 257 LYS B 258 SITE 4 AC3 15 ARG B 266 MAE B 414 HOH B 458 SITE 1 AC4 11 ARG A 292 VAL B 17 PHE B 18 VAL B 37 SITE 2 AC4 11 GLY B 38 TRP B 140 ASN B 194 ARG B 386 SITE 3 AC4 11 PLP B 413 HOH B 458 HOH B 464 CRYST1 56.400 126.000 124.300 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017730 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007937 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008045 0.00000 MTRIX1 1 0.937000 -0.349000 -0.030000 6.90700 1 MTRIX2 1 -0.349000 -0.937000 0.000000 29.36800 1 MTRIX3 1 -0.028000 0.011000 -1.000000 103.47000 1